Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-039022

SVP and General Counsel sold 2,880 shares at $46.68 ($134,438)

  • SVP and General Counsel acquired 2,880 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Taylor Stacy L · SVP and General Counsel

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-06-24 Exercise or conversion : show line 1 in the form +1,109 $7.80 $8,650 2,409 D
2020-06-24 Exercise or conversion : show line 2 in the form +1,771 $6.55 $11,600 4,180 D
2020-06-24 Sale : show line 3 in the form −2,880 $46.68 $134,438 1,300 D
Open-market sales · 2,880 sh · avg $46.68 · $134,438

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-06-24 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −1,109 39,472 D
2020-06-24 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −1,771 37,188 D
Loading xslF345X03/doc4.xml…